Decision: Favourable

Study Title:

A Randomized, Double-Blind, Placebo controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients with Uncontrolled Moderate to Severe Asthma

  • NREC Code:

    22-NREC-CT-090

  • Decision:

    Favourable

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Desmond Michael Murphy

  • PI Institution:

    Cork University Hospital

  • Sponsor:

    Sanofi-Aventis Recherche & Development

Scroll to Top